These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27486276)

  • 1. Pregnancy Outcome in Women with Mechanical Prosthetic Heart Valves Treated with Unfractionated Heparin (UFH) or Enoxaparin.
    Khader KA; Saad AS; Abdelshafy M
    J Obstet Gynaecol India; 2016 Oct; 66(5):321-6. PubMed ID: 27486276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin.
    McLintock C; McCowan LM; North RA
    BJOG; 2009 Nov; 116(12):1585-92. PubMed ID: 19681850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal and Fetal Outcomes in Pregnant Women with a Prosthetic Mechanical Heart Valve.
    Ayad SW; Hassanein MM; Mohamed EA; Gohar AM
    Clin Med Insights Cardiol; 2016; 10():11-7. PubMed ID: 26884686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome in women with mechanical prosthetic heart valvesat their first trimester of pregnancy treated with unfractionated heparin (UFH) or enoxaparin: A randomized clinical trial.
    Movahedi M; Motamedi M; Sajjadieh A; Bahrami P; Saeedi M; Saeedi M
    J Cardiovasc Thorac Res; 2020; 12(3):209-213. PubMed ID: 33123327
    [No Abstract]   [Full Text] [Related]  

  • 5. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant therapy in pregnant women with mechanical and bioprosthetic heart valves.
    Rhemtula HA; Schapkaitz E; Jacobson B; Chauke L
    Int J Gynaecol Obstet; 2024 Sep; ():. PubMed ID: 39340465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism and anticoagulant therapy in pregnancy.
    Greer IA
    Gend Med; 2005; 2 Suppl A():S10-7. PubMed ID: 16551552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature.
    Chan WS; Anand S; Ginsberg JS
    Arch Intern Med; 2000 Jan; 160(2):191-6. PubMed ID: 10647757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
    Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
    Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves.
    Steinberg ZL; Dominguez-Islas CP; Otto CM; Stout KK; Krieger EV
    J Am Coll Cardiol; 2017 Jun; 69(22):2681-2691. PubMed ID: 28571631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of low molecular weight heparin in pregnant women with mechanical heart valves.
    Yinon Y; Siu SC; Warshafsky C; Maxwell C; McLeod A; Colman JM; Sermer M; Silversides CK
    Am J Cardiol; 2009 Nov; 104(9):1259-63. PubMed ID: 19840573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enoxaparin treatment in women with mechanical heart valves during pregnancy.
    Rowan JA; McCowan LM; Raudkivi PJ; North RA
    Am J Obstet Gynecol; 2001 Sep; 185(3):633-7. PubMed ID: 11568791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation Regimens During Pregnancy in Patients With Mechanical Heart Valves: A Systematic Review and Meta-analysis.
    Xu Z; Fan J; Luo X; Zhang WB; Ma J; Lin YB; Ma SH; Chen X; Wang ZP; Ou JS; Zhang X
    Can J Cardiol; 2016 Oct; 32(10):1248.e1-1248.e9. PubMed ID: 26927861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Safety and Efficacy of Low-Molecular-Weight Heparin in Pregnant Women With Rheumatic Heart Disease and Valves Replacement.
    Alghamdi N; Alqahtani S; Allehyani L; Alosaimi H; Almutairi W; Alobaid S; Albackr HB; Aldakhil L; Alotaibi GS; Alqahtani FH
    Cureus; 2022 Mar; 14(3):e23052. PubMed ID: 35464573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin versus Unfractionated Heparin for the Perioperative Anticoagulant Therapy in Patients with Mechanical Prosthetic Heart Valve Undergoing Non-Cardiac Surgery.
    Iliuta L; Andronesi A; Camburu G; Rac-Albu M
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant management of pregnancy following heart valve replacement in the United Kingdom, 1986-2002.
    Shannon MS; Edwards MB; Long F; Taylor KM; Bagger JP; De Swiet M
    J Heart Valve Dis; 2008 Sep; 17(5):526-32. PubMed ID: 18980086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
    Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting.
    Menon H; Pillai A; Aussenberg-Rodriguez J; Ambrose J; Youssef I; Griffiths EA; Al Ustwani O
    Avicenna J Med; 2018; 8(4):133-138. PubMed ID: 30319954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.